1 |
0,25 mg rpc1063 |
- |
- |
- |
- |
096 1件: 96 💬 |
2 |
0.25 mg rpc1063 |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
3 |
0.25mg rpc1063 |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
4 |
0.5 mg rpc1063 |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
5 |
0.5mg rpc1063 |
- |
- |
- |
- |
013 1件: 13 💬 |
6 |
1 mg rpc1063 |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
7 |
1.0 mg rpc1063 |
- |
- |
- |
- |
097 1件: 97 💬 |
8 |
1.0mg rpc1063 |
- |
- |
- |
- |
013 1件: 13 💬 |
9 |
1mg rpc1063 |
- |
- |
- |
- |
096 1件: 96 💬 |
10 |
[14c]-rpc1063 solution (0.1 mg/ml) for oral administration |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
11 |
[rpc1063] |
- |
- |
- |
- |
096 1件: 96 💬 |
12 |
Rpc1063 |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
13 |
Rpc1063 (equivalent to ozanimod |
Ozanimod |
1件: D10968 D10968 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 1件: 96 💬 |
14 |
Rpc1063 (equivalent to ozanimod hcl) |
Ozanimod |
1件: D10968 D10968 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 1件: 96 💬 |